BioLineRx Ltd.
For the period ended Nov 24, 2025. Filed Nov 24, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Nov 24, 2025 · Filed Nov 24, 2025
Use the contents to explore the available documents and sections.
BLRX$1.71-3.3%Stored close · as of Nov 6, 2026
Contents
EX-99 · APHEXDA Performance Update
APHEXDA Performance Update
| • | APHEXDA generated sales of $2.4 million in the third quarter of 2025, providing royalty revenue to the Company of $0.4 million. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.